Amgen, Inc. (AMGN)
329.82
-16.43
(-4.75%)
USD |
NASDAQ |
May 01, 16:00
329.54
-0.28
(-0.08%)
After-Hours: 20:00
Amgen Free Cash Flow : 8.597B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.316B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 17.80B |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.189B |
| Cash from Investing (Quarterly) | -716.00M |
| Cash from Financing (Quarterly) | 1.436B |
| Free Cash Flow Per Share (Quarterly) | 2.715 |
| Free Cash Flow to Equity (Quarterly) | -411.00M |
| Free Cash Flow to Firm (Quarterly) | 2.063B |
| Free Cash Flow Yield | 4.80% |